Missouri Poll Shows Pro-Life Roy Blunt Clearly Leading Carnahan for Senate
by Steven Ertelt
September 23, 2010
Jefferson City, MO (LifeNews.com) — Pro-life Senate candidate Roy Blunt has a clear lead against pro-abortion Robin Carnahan according to the latest Rasmussen Reports telephone survey of likely voters in the Show Me state. He has maintained his lead from the last survey the respected polling firm took in August.
The poll has Blunt picking up 52% support, while Carnahan, Missouris secretary of state, gets 44% of the vote.
A total of 5 percent of Missouri voters favor another candidate or are still undecided.
Two weeks ago, Blunt led Carnahan by a 53% to 43% margin when leaners were included in the totals. Leaners are those who initially indicate no preference for either of the candidates but answer a follow-up question and say they are leaning towards a particular candidate.
"Results before leaners are added find Blunt with a 50% to 41% edge over Carnahan, showing little change over the past two weeks. From September of 2009 through late August, support for Blunt ranged from 44% to 51% in results excluding leaners. Carnahans support ranged from 40% to 46% over the same period," Rasmussen said.
While 75% of Blunts supporters are certain of their vote this November, 67% of Carnahans backers say the same.
Eighty-eight percent of Missouri Republicans back Blunt, while 86% of the states Democrats give their vote to Carnahan. Blunt leads Carnahan 59% to 33% among voters not affiliated with either major political party.
Blunt and Carnahan are running for the seat being vacated by retiring pro-life GOP Senator Christopher "Kit" Bond.
Rasmussen says the opposition to the pro-abortion ObamaCare bill is sparking support for Blunt.
"In Missouri, 64% of voters favor repeal of the new national health care law, which is slightly higher than results found nationwide. That number includes 54% who Strongly Favor repeal. Only 29% oppose repeal of the law, with 23% who Strongly Oppose it," the firm notes.
This summer, the bill received a major blow from voters in Missouri. They voted overwhelmingly to reject a federal mandate to purchase health insurance — important because some of the plans in the program will pay for abortions with federal funds.
Proposition C passed by almost a 3-1 ratio as Show Me State residents voted to exempt Missouri from the insurance mandate in the new health care law.
In July, Blunt picked up the endorsement from the Susan B. Anthony List.
SBA List Candidate Fund President Marjorie Dannenfelser said of the endorsement: The Senate is in great need of the pro-life statesmanship Roy Blunt has already proven time and again to possess."
"His commitment to rescind taxpayer funding of abortion in the federal health care legislation and in every aspect of federal spending is urgently needed in the coming Congress," she added.
Ironically, Roy Blunt represents womens real views and needs on the issue of abortion far better than does his female opponent, Dannenfelser said of the pro-abortion EMILYs List-endorsed candidate and vocal abortion supporter Carnahan.
The Missouri Right to Life political action committee announced in June its support for Blunt and noted Carnahan is pro-abortion.
As a seven-term Congressman, Rep. Blunt has been a consistent voice for life with a 100% pro-life voting record.
Missouri Right to Life greatly appreciates Roy Blunt’s commitment to the sanctity of human life, the group told LifeNews.com in making the endorsement announcement.
"Missouri Right to Life PAC urges Missourians who respect life to strongly support Roy Blunt’s campaign," Pam Fichter, the president of Missouri Right to Life, said.
Sign Up for Free Pro-Life News From LifeNews.com
Daily Pro-Life News Report Twice-Weekly Pro-Life
News Report Receive a free daily email report from LifeNews.com with the latest pro-life news stories on abortion, euthanasia and stem cell research. Sign up here. Receive a free twice-weekly email report with the latest pro-life news headlines on abortion, euthanasia and stem cell research. Sign up here.